Fact CheckerSign in

NCT03059121Completed

The Cleveland Cardiometabolic Cohort

Observational Study of Cardiometabolic Risk in HIV Infected Subjects After Initiation of Antiretroviral Therapy: The Cleveland Cardiometabolic Cohort

Source: ClinicalTrials.gov · Last updated 28 Jan 2026

Brief summary (registry, in English)

In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

Status (registry)
Completed
Study type
Observational
Enrollment
56 (actual)
First submitted
10 Feb 2017
Start date
1 Sept 2016
Primary completion date
19 May 2025
Lead sponsor
University Hospitals Cleveland Medical Center
Diseases
HIV
NCT number
NCT03059121

What you commit to

  • Study type: Observational
  • Participants enrolled: 56
  • From 1 Sept 2016 to the primary completion date, 19 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Pregnancy or lactation

Who the study is looking for

  • HIV-1 infection as documented by any licensed ELISA test kit and confirmed by Western blot at any time prior to study entry. HIV-1 culture, HIV-1 antigen, plasma HIV-1 RNA, or a second antibody test by a method other than ELISA is acceptable as an alternative confirmatory test
  • Provides written informed consent and is capable of reading and comprehending the informed consent
  • Is not currently taking antiretroviral therapy and has never been on such treatments in the past. Exception would be for subjects who had been in the past on ≤30 days cumulative antiretrovirals, as long as these were stopped \>6 months prior to study entry
  • Is planning on starting antiretroviral therapy as part of routine clinic care

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospitals Case Medical Center
Coordinator of this site? Confirm its status
ClevelandUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.